151 related articles for article (PubMed ID: 2730015)
1. [Infection and immunosuppression in cancer patients].
Kitahara T; Takenaka T; Yoshino M
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1108-14. PubMed ID: 2730015
[TBL] [Abstract][Full Text] [Related]
2. [Septicemia in children with malignant disease].
Hatae Y; Takeda T; Nakadate H; Hatayama Y; Kishino T; Ogawa Y
Gan To Kagaku Ryoho; 1990 Oct; 17(10):2077-81. PubMed ID: 2221930
[TBL] [Abstract][Full Text] [Related]
3. Bacteremia complicating acute leukemia with special reference to its incidence and changing etiological patterns.
Funada H; Machi T; Matsuda T
Jpn J Clin Oncol; 1988 Sep; 18(3):239-48. PubMed ID: 3411788
[TBL] [Abstract][Full Text] [Related]
4. Infections in children with cancer: a continued need for the comprehensive physical examination.
Auletta JJ; O'Riordan MA; Nieder ML
J Pediatr Hematol Oncol; 1999; 21(6):501-8. PubMed ID: 10598661
[TBL] [Abstract][Full Text] [Related]
5. Neonatal septicaemia in Ilorin: bacterial pathogens and antibiotic sensitivity pattern.
Mokuolu AO; Jiya N; Adesiyun OO
Afr J Med Med Sci; 2002 Jun; 31(2):127-30. PubMed ID: 12518907
[TBL] [Abstract][Full Text] [Related]
6. Infections in immunocompromised patients. I. Pathogenesis, etiology, and diagnosis.
Klastersky J
Clin Ther; 1985; 8(1):90-9. PubMed ID: 3914372
[TBL] [Abstract][Full Text] [Related]
7. Prevention of herpes zoster in patients by long-term oral acyclovir after allogeneic bone marrow transplantation.
Perren TJ; Powles RL; Easton D; Stolle K; Selby PJ
Am J Med; 1988 Aug; 85(2A):99-101. PubMed ID: 3044103
[TBL] [Abstract][Full Text] [Related]
8. Herpes infections in breast cancer patients treated with adjuvant chemotherapy.
Masci G; Magagnoli M; Gullo G; Morenghi E; Garassino I; Simonelli M; Santoro A
Oncology; 2006; 71(3-4):164-7. PubMed ID: 17641534
[TBL] [Abstract][Full Text] [Related]
9. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
10. Febrile neutropenia in cancer patients in a tertiary care medical center in Lebanon: microbial spectrum and outcome.
Hamzeh F; Kanj SS; Uwaydah M
J Med Liban; 2000; 48(3):136-42. PubMed ID: 11268566
[TBL] [Abstract][Full Text] [Related]
11. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
Ghalaut PS; Sen R; Dixit G
J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of infectious complications and immune recovery following high-dose chemotherapy (HDC) and autologous peripheral blood progenitor cell transplantation (PBPC-T) in 148 breast cancer patients.
Zambelli A; Montagna D; Da Prada GA; Maccario R; Zibera C; Moretta A; Ponchio L; Lozza L; Baiardi P; Maserati R; Marone P; Della Cuna GR
Anticancer Res; 2002; 22(6B):3701-8. PubMed ID: 12552979
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience with Oka live varicella vaccine in Japan.
Takahashi M; Kamiya H; Baba K; Asano Y; Ozaki T; Horiuchi K
Postgrad Med J; 1985; 61 Suppl 4():61-7. PubMed ID: 3014479
[TBL] [Abstract][Full Text] [Related]
14. [Late infectious complications after high-dose therapy and autologous blood stem cell transplantation].
Metzner B; Grüneisl R; Gebauer W; Reschke D; Ost E; Müller TH; Reichert D; Rosien B; Del Valle F; Zirpel I; Kohse KP; Schunter F; Illiger HJ
Med Klin (Munich); 2002 Nov; 97(11):650-8. PubMed ID: 12434273
[TBL] [Abstract][Full Text] [Related]
15. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
16. [Development of the risk of infection in the child with leukemia].
Lutz P; Delage G; Rivard GE; Berdnikoff G
Can Med Assoc J; 1983 Sep; 129(5):449-53. PubMed ID: 6576844
[TBL] [Abstract][Full Text] [Related]
17. [Herpes zoster in cancer patients].
Bogomolov BP; Bakhur EG
Ter Arkh; 1990; 62(1):99-103. PubMed ID: 2333632
[TBL] [Abstract][Full Text] [Related]
18. Herpes zoster in immunocompromised patients: incidence, timing, and risk factors.
Wung PK; Holbrook JT; Hoffman GS; Tibbs AK; Specks U; Min YI; Merkel PA; Spiera R; Davis JC; St Clair EW; McCune J; Ytterberg SR; Allen NB; Stone JH;
Am J Med; 2005 Dec; 118(12):1416. PubMed ID: 16378799
[TBL] [Abstract][Full Text] [Related]
19. Current therapy of varicella zoster virus infection in immunocompromised patients. A comparison of acyclovir and vidarabine.
Shepp DH; Dandliker PS; Meyers JD
Am J Med; 1988 Aug; 85(2A):96-8. PubMed ID: 3044102
[TBL] [Abstract][Full Text] [Related]
20. [Acyclovir therapy in varicella/zoster diseases in immunocompromised children with cancer].
Kuhn N; Landbeck G
Monatsschr Kinderheilkd; 1984 Feb; 132(2):105-9. PubMed ID: 6328285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
